Filing Details

Accession Number:
0000950170-24-131191
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-26 18:42:43
Reporting Period:
2024-11-22
Accepted Time:
2024-11-26 18:42:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1308547 Dolby Laboratories Inc. DLB Patent Owners & Lessors (6794) 900199783
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1894052 D John Couling C/O Dolby Laboratories, Inc.
1275 Market Street
San Francisco CA 94103
Svp, Entertainment No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2024-11-22 2,000 $81.00 106,806 No 4 S Direct
Class A Common Stock Acquisiton 2024-11-22 40,000 $33.15 146,806 No 4 M Direct
Class A Common Stock Acquisiton 2024-11-22 8,000 $64.60 154,806 No 4 M Direct
Class A Common Stock Disposition 2024-11-22 48,000 $80.00 106,806 No 4 S Direct
Class A Common Stock Acquisiton 2024-11-25 7,000 $64.60 113,806 No 4 M Direct
Class A Common Stock Disposition 2024-11-25 7,000 $80.50 106,806 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Option (Right to Buy) Disposition 2024-11-22 40,000 $0.00 40,000 $33.15
Class A Common Stock Employee Stock Option (Right to Buy) Disposition 2024-11-22 8,000 $0.00 8,000 $64.60
Class A Common Stock Employee Stock Option (Right to Buy) Disposition 2024-11-25 7,000 $0.00 7,000 $64.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-12-15 No 4 M Direct
7,000 2025-12-17 No 4 M Direct
0 2025-12-17 No 4 M Direct
Footnotes
  1. Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
  2. Shares include 239 shares and 48 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2024 and November 15, 2024, respectively.
  3. This option was granted for a total of 40,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.
  4. This performance-based stock option award was granted for a total of 20,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 75% of target, or 15,000 shares.